Speaker illustration

Professor David Lanfear

Henry Ford Hospital, Detroit (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Professor DAVID E. LANFEAR, MD, MS is Vice President, Clinical and Translational Research and Co-Director of the Center for Individualized and Genomic Medicine Research at Henry Ford Health. Dr. Lanfear is a Heart Failure Physician and Scientist with a track record of clinical trial leadership and NIH funded projects focused on precision medicine and genomics in heart failure. He has more than 150 published manuscripts reaching high-impact journals including NEJM, JAMA, JACC, and Circulation: Heart Failure. Dr. Lanfear is an Associate Editor at Circulation: Heart Failure and a national leader in academic societies serving currently on ACC Accreditation Oversight Committee, AHA GPM Nominating committee, HFSA Program Committee, and having previously served on the ACC Heart Failure/Tx leadership committee, AHA Genomics and Precision Medicine Leadership committee, and HFSA Board of Directors.

Mitochondrial function is abnormal in circulating blood monocytes of patients with chronic heart failure

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Further insights into inflammation, immunology, and insulin resistance in heart failure


Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction

Event: ESC Congress 2019

Topic: Biomarkers

Session: Obesity in Heart Failure


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb